We suggest that apoptosis of PBL was mainly owed to Fas–FasL interaction for the following reasons: Addition of an anti-Fas blocking antibody reverted the effect of CRH-treated ovarian cancer cells, by significantly reducing the numbers of apoptotic PBL. This evidence concerns the gene CRH and ovarian carcinoma.